Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Curr Gastroenterol Rep. 2014 Jan;16(1):370. doi: 10.1007/s11894-013-0370-0

Table 3.

A summary of clinical trials of low FODMAPs diet

Ref # Design Study population Intervention Time Outcome measures Symptom improvement Compliance Additional Outcomes
32 Non- randomized, retrospective observational IBS patients; standard diet group=39, low FODMAP group=43 Low FODMAP or NICE dietary guidelines (fiber, probiotics, exclusion diets), breath tests. 2–6 m Change in symptoms (7-point Likert scale) and diet satisfaction (5-point Likert scale). Composite symptom score improved in 86% vs. 49% (low FODMAP vs. standard group) (P<0.001). 84% of low FODMAP group assessed; 64% adhered strictly, 30% ~ 50% of the time. Satisfaction= 76% vs. 54% (low FODMAP vs. standard group, P=0.038).
27 Double blind, randomized placebo controlled quadruple-armed IBS (12 IBS-D, 5 IBS-C and 8 IBS-M) with FM; responded to low FODMAP diet for 3 months Patients received 3 doses of either fructans (7,14, or 19 g/3 days), fructose (14,28,50 g/3 days), fructans + fructose or glucose (7,14,20g/8 days) 22 w Daily symptom assessments and adherence to diet through daily food diaries 70% on fructose, 77% on fructans and 79% on fructose + fructans had symptom relapse (gas, bloating, pain) compared to 14% on glucose (P<0.001) Diet adherence was > 95%. Higher doses of fructose and/or fructans associated with more severe symptoms (P<0.01) but not with glucose.
33 Non- randomized prospective observational 90 IBS patients referred for lactose and fructose breath testing All received high and low FODMAPs lists, recipes, reintroduction of restricted foods guidelines and consultation with dietitian. Mean total 15.7 m GI symptom questionnaire (7 point Likert) at baseline and 6 weeks. Adherence and opinion of diet. Improvement (P<0.05) in all symptoms except feeling full, burping and passage of mucus. 76% adherent 50% of the time or more. Satisfied= 77%; easy to follow diet= 50%. Presence of FM strongly associated with efficacy.
34 Randomized controlled single-blind crossover 30 IBS patients (10 IBS-D, 13 IBC-C, 5 IBS-M and 2 IBS-U) vs. 8 healthy controls Average of 3.05 g FODMAP/day. Control diet = average of 23.7 g FODMAP per day. 21 d per diet Daily food records and symptoms; differences in individual & overall symptoms, King’s stool chart & fecal water content. Improvement in 70% of patients, including 70% with FM, 60% without FM and 75% no prior breath test. Pain, bloating and dissatisfaction with stool consistency improved (P<0.001) especially IBS-D. Adherent= at least 17/21 days (80%); control diet=100%; low FODMAP diet= 80%. None.
35 Randomized single-blind crossover study 15 IBS patients (4 IBS-D, 8 IBS- C, 2 IBS-M, 2 IBS-U) vs. 15 healthy controls Low (9 g) or high (50 g) FODMAP for 2 days. Breath samples collected on day 2 of study. 2 d per diet Breath H2, CH4 and symptoms measured on a Likert 0 to 3 scale Abdominal pain, bloating, gas, heartburn, nausea and lethargy reduced in IBS patients when on low FODMAP diet. Gas lower in healthy patients on the low FODMAP diet. Not assessed. AUC for H2 (not CH4) higher with high vs. low FODMAP diet in both normal and IBS.

Ref#; references, IBS-D, C, M; irritable bowel syndrome-diarrhea, constipation and mixed type, FM; fructose malabsorption, H2; hydrogen, CH4; methane, AUC; area under the curve